S&B Pharma LLC DBA Norac Pharma has submitted an application to the Drug Enforcement Administration (DEA) to register as an importer of certain controlled substances. The company intends to import intermediate forms of Tapentadol for further manufacturing and ANPP for producing other controlled substances. Public comments or objections to this application can be submitted electronically by March 28, 2025. The DEA will only approve import permits if the company's activities comply with specific federal regulations.
Simple Explanation
S&B Pharma wants permission from a special U.S. agency to bring in certain powerful medicine ingredients from other countries to make new medicines. People can tell the agency if they think this is okay or not until almost the end of March 2025.